These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24852924)

  • 21. Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease.
    da Silva AM; Vilhena E; Lopes A; Santos E; Gonçalves MA; Pinto C; Moreira I; Mendonça D; Cavaco S
    J Neurol Sci; 2011 Jul; 306(1-2):66-70. PubMed ID: 21497358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of multiple sclerosis in a population-based cohort.
    Debouverie M; Pittion-Vouyovitch S; Louis S; Guillemin F;
    Eur J Neurol; 2008 Sep; 15(9):916-21. PubMed ID: 18637953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis relapses and depression.
    Moore P; Hirst C; Harding KE; Clarkson H; Pickersgill TP; Robertson NP
    J Psychosom Res; 2012 Oct; 73(4):272-6. PubMed ID: 22980532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status.
    Merlino G; Fratticci L; Lenchig C; Valente M; Cargnelutti D; Picello M; Serafini A; Dolso P; Gigli GL
    Sleep Med; 2009 Jan; 10(1):26-34. PubMed ID: 18207453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
    Haase R; Piatkowski J; Ziemssen T
    Altern Ther Health Med; 2011; 17(6):22-8. PubMed ID: 22314716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
    Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
    Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
    Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
    Chruzander C; Ytterberg C; Gottberg K; Einarsson U; Widén Holmqvist L; Johansson S
    J Neurol Sci; 2014 Apr; 339(1-2):57-63. PubMed ID: 24492009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS.
    Simpson S; Taylor KL; Jelinek GA; De Livera AM; Brown CR; O'Kearney E; Neate SL; Bevens W; Weiland TJ
    Mult Scler Relat Disord; 2019 May; 30():165-175. PubMed ID: 30785073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
    Shirani A; Zhao Y; Kingwell E; Rieckmann P; Tremlett H
    Mult Scler; 2012 Apr; 18(4):442-50. PubMed ID: 21952097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
    McKay KA; Tremlett H; Fisk JD; Zhang T; Patten SB; Kastrukoff L; Campbell T; Marrie RA;
    Neurology; 2018 Apr; 90(15):e1316-e1323. PubMed ID: 29523642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
    Kisic Tepavcevic D; Pekmezovic T; Stojsavljevic N; Kostic J; Dujmovic Basuroski I; Mesaros S; Drulovic J
    Acta Neurol Belg; 2013 Dec; 113(4):403-9. PubMed ID: 23460394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predicting factors for depression in multiple sclerosis].
    Alarcia R; Ara JR; Martín J; Bertol V
    Neurologia; 2004 Sep; 19(7):364-8. PubMed ID: 15273883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
    Knippenberg S; Bol Y; Damoiseaux J; Hupperts R; Smolders J
    Acta Neurol Scand; 2011 Sep; 124(3):171-5. PubMed ID: 20880265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic indicators for long-term disability in multiple sclerosis patients.
    Damasceno A; Von Glehn F; Brandão CO; Damasceno BP; Cendes F
    J Neurol Sci; 2013 Jan; 324(1-2):29-33. PubMed ID: 23073568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mental health outcome of long-term and episodic adolescent depression: 15-year follow-up of a community sample.
    Jonsson U; Bohman H; von Knorring L; Olsson G; Paaren A; von Knorring AL
    J Affect Disord; 2011 May; 130(3):395-404. PubMed ID: 21112639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
    Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F
    Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.